Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8926624rdf:typepubmed:Citationlld:pubmed
pubmed-article:8926624lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:8926624lifeskim:mentionsumls-concept:C0028944lld:lifeskim
pubmed-article:8926624lifeskim:mentionsumls-concept:C0018284lld:lifeskim
pubmed-article:8926624lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:8926624lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:8926624pubmed:issue1lld:pubmed
pubmed-article:8926624pubmed:dateCreated1996-11-27lld:pubmed
pubmed-article:8926624pubmed:abstractTextOligodendrocytes are responsible for myelination of axons within the central nervous system and are lost in the lesions of multiple sclerosis. The question of whether mature oligodendrocytes are capable of division, and hence of giving rise to new myelinating cells, remains controversial. We have studied the response in vitro of rat oligodendrocytes to growth factors. Unlike their progenitors which divided vigorously in response to growth factor stimulation, mature oligodendrocytes showed no mitotic response to a number of individual growth factors. However, when exposed to basic fibroblast growth factor (bFGF), mature oligodendrocytes expressed the immediate response gene c-fos and the cell cycle-associated protein proliferating cell nuclear antigen, but failed to divide and ultimately underwent cell death by apoptosis. These findings are consistent with the emerging view that mitosis and apoptosis are closely linked phenomena.lld:pubmed
pubmed-article:8926624pubmed:languageenglld:pubmed
pubmed-article:8926624pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8926624pubmed:citationSubsetIMlld:pubmed
pubmed-article:8926624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8926624pubmed:statusMEDLINElld:pubmed
pubmed-article:8926624pubmed:monthAprlld:pubmed
pubmed-article:8926624pubmed:issn0360-4012lld:pubmed
pubmed-article:8926624pubmed:authorpubmed-author:CompstonD ADAlld:pubmed
pubmed-article:8926624pubmed:authorpubmed-author:MuirD ADAlld:pubmed
pubmed-article:8926624pubmed:issnTypePrintlld:pubmed
pubmed-article:8926624pubmed:day1lld:pubmed
pubmed-article:8926624pubmed:volume44lld:pubmed
pubmed-article:8926624pubmed:ownerNLMlld:pubmed
pubmed-article:8926624pubmed:authorsCompleteYlld:pubmed
pubmed-article:8926624pubmed:pagination1-11lld:pubmed
pubmed-article:8926624pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:meshHeadingpubmed-meshheading:8926624-...lld:pubmed
pubmed-article:8926624pubmed:year1996lld:pubmed
pubmed-article:8926624pubmed:articleTitleGrowth factor stimulation triggers apoptotic cell death in mature oligodendrocytes.lld:pubmed
pubmed-article:8926624pubmed:affiliationUniversity of Cambridge Neurology Unit, Addenbrooke's Hospital, England.lld:pubmed
pubmed-article:8926624pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8926624pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8926624lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8926624lld:pubmed